Search

for
Search:

Sort by

Research

600-630 / 1000+ results

Tofacitinib for the Treatment of Three Immune-Mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata

research Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata

5 citations , January 2021 in “Inflammatory Bowel Diseases”

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

The FDA Approves Litfulo® (Ritlecitinib) for the Treatment of Severe Alopecia Areata in Adolescents and Adults

research La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos

September 2023 in “Medicina Estética Revista Científica de la Sociedad Española de Medicina Estética (SEME)”

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

$Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus$

research Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus

16 citations , June 2017 in “JAMA Dermatology”

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

research Arterial embolization caused by injection of hyaluronic acid (RestylaneR)

419 citations , May 2002 in “British journal of dermatology/British journal of dermatology, Supplement”

Hyaluronic acid injections can cause serious artery blockages, so practitioners must be careful.

research Fever, Maculopapular Rash and Severe Aphthous Stomatitis in a Renal Transplant Patient

December 2013 in “American journal of transplantation”

The patient improved after antiviral treatment for a viral infection.

research 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata

July 2024 in “Journal of Investigative Dermatology”

ITK inhibitors may effectively treat alopecia areata.

research The effect of polyphloretin phosphate, polyoestradiol phosphate, a diphosphonate and a polyphosphate on calcification induced by dihydrotachysterol in skin, aorta and kidney of rats

31 citations , February 1972 in “Experientia”

The diphosphonate was the most effective at preventing calcification in rats.

research P4 Outcome following switch between brand name and generic tacrolimus in paediatric population

3 citations , January 2018 in “Archives of Disease in Childhood”

Switching to generic tacrolimus was safe, effective, and saved money.

research Enzalutamide/finasteride/goserelin/zoledronic-acid

July 2024 in “Reactions Weekly”

Embryo-Fetal Developmental Toxicity and Toxicokinetics Studies of YWS1903, a Novel Potassium-Competitive Acid Blocker, in Pregnant Rats

research Embryo‐Fetal Developmental Toxicity and Toxicokinetics Studies of YWS1903, a Novel Potassium‐Competitive Acid Blocker, in Pregnant Rats

May 2025 in “Birth Defects Research”

YWS1903 is safe for pregnant rats at moderate doses but causes fetal issues at high doses.

research The protoporphyrin IX dimethyl ester incorporated soy lecithin for photoinactivation of fluconazole-resistant Candida albicans

September 2015 in “Photodiagnosis and Photodynamic Therapy”

research Potent Efficacy of Computer-Aided Designed Peptide Degrader Drug on PCSK9-Mediated Hypercholesterolemia

2 citations , June 2025

Cadd4 effectively reduces cholesterol levels without side effects.

Short-Term Rho-Associated Kinase Inhibitor Treatment Accelerates Primary Keratinocyte Growth Without Affecting the Stem Cell Population

research 557 Short-term Rho-associated kinase inhibitor treatment accelerates primary keratinocyte growth without affecting the characteristics of the stem cell population

November 2022 in “Journal of Investigative Dermatology”

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

research Toxic epidermal necrolysis caused by skin hypersensitivity to monosulfiram.

9 citations , March 1968 in “The BMJ”

A woman's severe skin reaction was caused by an allergy to a skin treatment.

research Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.

91 citations , April 2006 in “PubMed”

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Diagnostic Applications and Therapeutic Options of Cascade CRISPR/Cas in the Modulation of miRNA in Diverse Cancers: Promises and Obstacles

research Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles

11 citations , May 2023 in “Journal of Cancer Research and Clinical Oncology”

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Protective Effect of Tribulus Terrestris on Hepato-Biochemical Parameters of Albino Rat After Treatment With Drug Cyproterone Acetate

research PROTECTIVE EFFECT OF TRIBULUS TERRESTRIS ON HEPATO-BIOCHEMICAL PARAMETERS OF ALBINO RAT AFTER TREATMENT WITH DRUG CYPROTERONE ACETATE

December 2023 in “Journal of Science Innovations and Nature of Earth”

Tribulus terrestris may protect the liver from drug damage.

research Diffuse plate-like sheets of desquamation

2 citations , January 2022 in “JAAD Case Reports”

The rash resolved after stopping ponatinib.

research The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma

21 citations , November 2018 in “Journal of the European Academy of Dermatology and Venereology”

The combination of encorafenib and binimetinib caused few skin issues.

research Morphologic and molecular characterization of two novel Krt71 (Krt2-6g) mutations: Krt71 rco12 and Krt71 rco13

51 citations , December 2006 in “Mammalian Genome”

research Clascoterone as a novel treatment for androgenetic alopecia

5 citations , May 2020 in “Clinical and Experimental Dermatology”

Clascoterone may be a promising treatment for hair loss.

research Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH

21 citations , April 2016 in “International Journal of Oncology”

GnRH treatment can reduce breast cancer cell invasion.

research PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors)

August 2025 in “JEADV Clinical Practice”

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

← Previous page Next page →